Your browser doesn't support javascript.
loading
Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.
Schmidt, Janine; Gong, Shunyou; Marafioti, Teresa; Mankel, Barbara; Gonzalez-Farre, Blanca; Balagué, Olga; Mozos, Ana; Cabeçadas, José; van der Walt, Jon; Hoehn, Daniela; Rosenwald, Andreas; Ott, German; Dojcinov, Stefan; Egan, Caoimhe; Nadeu, Ferran; Ramis-Zaldívar, Joan Enric; Clot, Guillem; Bárcena, Carmen; Pérez-Alonso, Vanesa; Endris, Volker; Penzel, Roland; Lome-Maldonado, Carmen; Bonzheim, Irina; Fend, Falko; Campo, Elias; Jaffe, Elaine S; Salaverria, Itziar; Quintanilla-Martinez, Leticia.
Affiliation
  • Schmidt J; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany;
  • Gong S; Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD;
  • Marafioti T; Department of Cellular Pathology, Barts and The London NHS Trust, London, United Kingdom;
  • Mankel B; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany;
  • Gonzalez-Farre B; Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
  • Balagué O; Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
  • Mozos A; Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain;
  • Cabeçadas J; Pathology Department, Instituto Portugues de Oncología, Lisboa, Portugal;
  • van der Walt J; Department of Histopathology, Guy's and St. Thomas Hospitals, London, United Kingdom;
  • Hoehn D; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY;
  • Rosenwald A; Institute of Pathology, University of Würzburg, and Comprehensive Cancer Center Mainfranken, Würzburg, Germany;
  • Ott G; Department of Clinical Pathology, Robert-Bosch-Hospital and Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;
  • Dojcinov S; Department of Pathology, All Wales Lymphoma Panel, University Hospital of Wales, Cardiff, United Kingdom;
  • Egan C; Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD;
  • Nadeu F; Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
  • Ramis-Zaldívar JE; Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
  • Clot G; Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
  • Bárcena C; Hospital Universitario 12 de Octubre, Madrid, Spain;
  • Pérez-Alonso V; Hospital Universitario 12 de Octubre, Madrid, Spain;
  • Endris V; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; and.
  • Penzel R; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; and.
  • Lome-Maldonado C; Department of Pathology, Instituto Nacional de Cancerologia, Mexico City, Mexico.
  • Bonzheim I; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany;
  • Fend F; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany;
  • Campo E; Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
  • Jaffe ES; Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD;
  • Salaverria I; Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
  • Quintanilla-Martinez L; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany;
Blood ; 128(8): 1101-11, 2016 08 25.
Article in En | MEDLINE | ID: mdl-27257180
ABSTRACT
Pediatric-type follicular lymphoma (PTFL) is a variant of follicular lymphoma (FL) with distinctive clinicopathological features. Patients are predominantly young males presenting with localized lymphadenopathy; the tumor shows high-grade cytology and lacks both BCL2 expression and t(14;18) translocation. The genetic alterations involved in the pathogenesis of PTFL are unknown. Therefore, 42 PTFL (40 males and 2 females; mean age, 16 years; range, 5-31) were genetically characterized. For comparison, 11 cases of conventional t(1418)(-) FL in adults were investigated. Morphologically, PTFL cases had follicular growth pattern without diffuse areas and characteristic immunophenotype. All cases showed monoclonal immunoglobulin (IG) rearrangement. PTFL displays low genomic complexity when compared with t(14;18)(-) FL (mean, 0.77 vs 9 copy number alterations per case; P <001). Both groups presented 1p36 alterations including TNFRSF14, but copy-number neutral loss of heterozygosity (CNN-LOH) of this locus was more frequently observed in PTFL (40% vs 9%; P =075). TNFRSF14 was the most frequently affected gene in PTFL (21 mutations and 2 deletions), identified in 54% of cases, followed by KMT2D mutations in 16%. Other histone-modifying genes were rarely affected. In contrast, t(14;18)(-) FL displayed a mutational profile similar to t(14;18)(+) FL. In 8 PTFL cases (19%), no genetic alterations were identified beyond IG monoclonal rearrangement. The genetic landscape of PTFL suggests that TNFRSF14 mutations accompanied by CNN-LOH of the 1p36 locus in over 70% of mutated cases, as additional selection mechanism, might play a key role in the pathogenesis of this disease. The genetic profiles of PTFL and t(14;18)(-) FL in adults indicate that these are two different disorders.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Genetic Predisposition to Disease / Receptors, Tumor Necrosis Factor, Member 14 / Genome-Wide Association Study / Mutation Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: Blood Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Genetic Predisposition to Disease / Receptors, Tumor Necrosis Factor, Member 14 / Genome-Wide Association Study / Mutation Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: Blood Year: 2016 Document type: Article